Target intelligence / Profile preview

Clathrin coat assembly protein AP180 (SNAP91)

Target
SNAP91
Molecular classification
Other (Endocytic adaptor protein; Clathrin-associated adaptor protein)
01

Overview

Clathrin coat assembly protein AP180 (SNAP91) is a neuronal endocytic adaptor protein essential for clathrin-mediated endocytosis, especially at synaptic membranes. It contains specialized domains, including an intrinsically disordered region that promotes membrane curvature and an ANTH domain that binds to SNARE motifs, supporting both assembly of clathrin coats and selective sorting of vesicular proteins such as synaptobrevin 2. SNAP91 ensures proper synaptic vesicle recycling; disruptions in its function lead to deficits in neurotransmission and have been linked to neurological diseases such as Alzheimer's disease and epileptic seizures. Genetic studies also suggest an association with craniofacial disorders such as cleft lip/palate, but the gene's primary expression is in the adult brain. There are currently no known approved drugs that directly interact with SNAP91, and it is not established as a therapeutic target in current clinical practice.

Other names
AP180CALMKIAA0656F1-20Clathrin coat-associated protein AP180Synaptosomal-associated protein 91Synaptosome associated protein 91kDaPhosphoprotein F1-20Clathrin assembly lymphoid myeloid leukemia proteinC-AP180mKIAA0656
02

Biological functions

Clathrin-mediated endocytosisClathrin coat assemblyVesicle traffickingRegulation of synaptic vesicle recyclingSNARE sorting
03

Disease associations

Neurodegenerative disease (notably Alzheimer's disease)Neurological disorders (epileptic seizures, cognitive decline)Craniofacial developmental disorders (cleft lip/palate)
04

Biomarkers

Biomarker of Alzheimer's disease

Beyond the preview

Go deeper on Clathrin coat assembly protein AP180 (SNAP91).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clathrin coat assembly protein AP180 (SNAP91).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call